Case number 1:20-cv-00090
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 15, 2021 | 24 | Order Reassigning Case (1) Docket Text: ORDER TRANSFERRING CASE. Case reassigned to District Judge Thomas S. Kleeh for all further proceedings. Senior Judge Irene M. Keeley no longer assigned to case. Signed by Senior Judge Irene M. Keeley on 9/15/21. (mh) |
| Sep 14, 2021 | 23 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Inc. for proceedings held on 8/16/2021 before Judge Keeley. (ck) |
| Sep 14, 2021 | 22 | Transcript Purchase Order - NON-APPELLATE (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Boehringer Ingelheim Corporation for proceedings held on 8/16/2021 before Judge Keeley. (ck) |
| Sep 14, 2021 | 21 | Transcript (12) Docket Text: TRANSCRIPT of status conference held on 8/16/2021, before Judge Keeley. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 10/5/2021. Redacted Transcript Deadline set for 10/15/2021. Release of Transcript Restriction set for 12/13/2021. (ck) |
| Jul 27, 2021 | 20 | Order (1) Docket Text: ORDER SCHEDULING STATUS CONFERENCE for 8/16/2021 11:30 AM via zoom before Senior Judge Irene M. Keeley. Signed by Senior Judge Irene M. Keeley on 7/27/21. (mh) |
| Jul 11, 2021 | N/A | Notice (Other) (0) Docket Text: IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Preparing for NextGen CM/ECF is a two-step process. Step One was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-filing account in the new NextGen CM/ECF system on or after July 19, 2021. Instructions for linking your account can be found here. PLEASE NOTE: The WVND CM/ECF system will be unavailable from 1:00 pm on Friday July 16, 2021 until 8:00 am Monday, July 19, 2021. An extension for electronic filing will be granted for all documents with court-imposed deadlines falling between 1:00 pm on Friday, July 16, 2021, and midnight on Sunday, July 18, 2021. All documents due during that period must be filed prior to 1:00 pm Friday, July 16, 2021, or on Monday, July 19, 2021. If you have any additional questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
| Jun 19, 2021 | N/A | Notice (Other) (0) Docket Text: IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM?ECF system to Next Generation of CM/ECF (NextGen CM/ECF) on Monday, July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Preparing for NextGen Cm/ECF is a two-step process. Step one was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-fling account in the new NextGen CM/ECF system on or after July 19, 2021. Please log in to the WVND CM/ECF system at https://ecf.wvnd.uscourts.gov/ before July 19, 2021 to make sure you know your current WVND e-filing login and password. Do not rely on your username and password being saved in your web browser, because that method will not work with the NextGen upgrade. If you do not know your login or password or have any additional questions please call the WVND Clerks CM/ECF Office Help Desk at (304) 267-5682. (cmd) (ADI) |
| May 30, 2021 | N/A | Notice (Other) (0) Docket Text: IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here.Currently, many attorneys within a firm may share a single PACER account. This will no longer be allowed with the New WVND NextGen CM/ECF system because each attorney must have an individual upgraded PACER account that will be linked to their e-filing account. Shared PACER accounts cannot be used by WVND e-filing attorneys once the WVND NextGen CM/ECF system is implemented. Preparing for NextGen CM/ECF is a two-step process. Step one is to upgrade your PACER account, and step two is to link your upgraded PACER account to the WVND e-filing account in the upgraded NextGen CM/ECF system. This notice only addresses the first step because the second step cant be completed until on or after July 19, 2021. The first step is to check and see if your PACER account is an upgraded PACER account. Many PACER accounts have already been upgraded. If any of the following is true, you have un upgraded PACER account and no action is required until after the WVND NextGen CM/ECF upgrade occurs on July 19, 2021: 1) You have a an upgraded PACER account for another NextGen court; or 2) Your PACER account was created after August 10, 2014. If none of these are true, you must upgrade your legacy PACER account before you will be able to link your PACER account to your current WVND CM/ECF account for your new NextGen CM/ECF account. Additional notices will be sent later detailing how to handle the second step in this process. If you still have questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
| Apr 23, 2021 | N/A | Set/Reset Deadlines (0) Docket Text: Set/Reset Deadlines per de 148 entered in 1:20cv19 ( Discovery due by 7/16/2021.), Set/Reset Hearings:( Bench Trial set for 1/24/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Pretrial Conference set for 1/14/2022 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Settlement Conference set for 1/14/2022 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Bench Trial set for 1/25/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Bench Trial set for 1/26/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Bench Trial set for 1/27/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley., Bench Trial set for 1/28/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley.) (jss) |
| Jan 22, 2021 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: Claim construction hearing set for 2/10/2021 10:00 AM before Senior Judge Irene M. Keeley per de 98 Order entered in 1:20cv19. (jss) |
| Jul 13, 2020 | N/A | Paperless Order (0) Docket Text: PAPERLESS ORDER. For reasons appearing to the Court, the Scheduling Conference set for 7/24/2020, 2:30 PM, is CANCELED. Signed by Senior Judge Irene M. Keeley on 7/13/2020. (dk) |
| Jul 8, 2020 | 18 | Scheduling Order (5) Docket Text: CONSENT ORDER OF CONSOLIDATION FOR ALL PURPOSESAND SCHEDULING ORDER: Initial Disclosures due by 1/27/2020. Claim Construction Hearing set for 1/20/2021 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. Telephonic Status Conference set for 7/20/2021 01:00 PM before Senior Judge Irene M. Keeley. Dispositive Motions due by 10/10/2021. Proposed Pretrial Order due by 12/17/2021. Final Pretrial Conference set for 1/14/2022 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. Bench Trial set for 1/24/2022 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. (5 days) Signed by Senior Judge Irene M. Keeley on 7/8/20. (jss) |
| May 19, 2020 | 17 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation. All Defendants. (Companion, James) |
| May 19, 2020 | 16 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [9] Motion for Jeanna Wacker to Appear Pro Hac Vice on behalf of Plaintiffs. Signed by Senior Judge Irene M. Keeley on 5/19/20. (mh) |
| May 19, 2020 | 15 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [8] Motion for Mira Atanassova Mulvaney to Appear Pro Hac Vice on behalf of Plaintiffs. Signed by Senior Judge Irene M. Keeley on 5/19/20. (mh) |
| May 19, 2020 | 14 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [10] Motion for James F. Hurst to Appear Pro Hac Vice on behalf of Plaintiffs. Signed by Senior Judge Irene M. Keeley on 5/19/20. (mh) |
| May 19, 2020 | 13 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [11] Motion for Bryan S. Hales to Appear Pro Hac Vice on behalf of Plaintiffs. Signed by Senior Judge Irene M. Keeley on 5/19/20. (mh) |
| May 18, 2020 | 11 | Motion for Leave to Appear (Main Document) (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bryan S. Hales by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Attachment State Bars where admitted, # (2) Proposed Order)(Companion, James) |
| May 18, 2020 | 11 | Motion for Leave to Appear (Attachment State Bars where admitted) (1) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bryan S. Hales by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Attachment State Bars where admitted, # (2) Proposed Order)(Companion, James) |
| May 18, 2020 | 11 | Motion for Leave to Appear (Proposed Order) (1) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bryan S. Hales by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Attachment State Bars where admitted, # (2) Proposed Order)(Companion, James) |
| May 18, 2020 | 10 | Motion for Leave to Appear (Proposed Order) (1) Docket Text: MOTION for Leave to Appear Pro Hac Vice of James F. Hurst by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 18, 2020 | 10 | Motion for Leave to Appear (Main Document) (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of James F. Hurst by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 18, 2020 | 9 | Motion for Leave to Appear (Proposed Order) (1) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jeanna Wacker by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 18, 2020 | 9 | Motion for Leave to Appear (Main Document) (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jeanna Wacker by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 18, 2020 | 8 | Motion for Leave to Appear (Proposed Order) (1) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Mira Atanassova Mulvaney by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 18, 2020 | 8 | Motion for Leave to Appear (Main Document) (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Mira Atanassova Mulvaney by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| May 12, 2020 | 7 | FirstOrder (3) Docket Text: FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 6/22/2020. Rule 26 Meeting Report due by 7/10/2020. Scheduling Conference set for 7/24/2020 02:30 PM in Senior Judge Irene M. Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 7/31/2020. Signed by Senior Judge Irene M. Keeley on 5/12/20. (mh) |
| May 12, 2020 | 6 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. (Copland, Gordon) |
| May 12, 2020 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: Scheduling Conference set for 7/24/2020 02:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. (Set to change location only) (mh) |
| May 11, 2020 | 5 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (jss) |
| May 8, 2020 | 4 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION to Attorneys Wacker, Mulvaney, Hurst and Hales. (mh) |
| May 8, 2020 | 3 | Other Document (2) Docket Text: Supplemental Information for Patent Cases Involving an Abbreviated new Drug Application (ANDA) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (mh) |
| May 8, 2020 | 2 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (mh) |
| May 8, 2020 | 1 | Complaint (Civil Cover Sheet) (2) Docket Text: COMPLAINT against Mylan Defendants, filed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation. Filing Fee $400. Receipt #0424-3038622 (Attachments: # (1) Exhibit 1 - Patent Information, # (2) Exhibit 2 - Patent Information, # (3) Civil Cover Sheet)(mh) |
| May 8, 2020 | 1 | Complaint (Exhibit 2 - Patent Information) (30) Docket Text: COMPLAINT against Mylan Defendants, filed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation. Filing Fee $400. Receipt #0424-3038622 (Attachments: # (1) Exhibit 1 - Patent Information, # (2) Exhibit 2 - Patent Information, # (3) Civil Cover Sheet)(mh) |
| May 8, 2020 | 1 | Complaint (Exhibit 1 - Patent Information) (30) Docket Text: COMPLAINT against Mylan Defendants, filed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation. Filing Fee $400. Receipt #0424-3038622 (Attachments: # (1) Exhibit 1 - Patent Information, # (2) Exhibit 2 - Patent Information, # (3) Civil Cover Sheet)(mh) |
| May 8, 2020 | 1 | Complaint (Main Document) (14) Docket Text: COMPLAINT against Mylan Defendants, filed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation. Filing Fee $400. Receipt #0424-3038622 (Attachments: # (1) Exhibit 1 - Patent Information, # (2) Exhibit 2 - Patent Information, # (3) Civil Cover Sheet)(mh) |
